Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis C

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    April 2019
  1. PRENTOE J, Velazquez-Moctezuma R, Augestad EH, Galli A, et al
    Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.
    Proc Natl Acad Sci U S A. 2019 Apr 30. pii: 1822002116.
    PubMed     Text format     Abstract available


    January 2019
  2. WILSON DJ
    The harmonic mean p-value for combining dependent tests.
    Proc Natl Acad Sci U S A. 2019;116:1195-1200.
    PubMed     Text format     Abstract available


  3. PETHE MA, Rubenstein AB, Khare SD
    Data-driven supervised learning of a viral protease specificity landscape from deep sequencing and molecular simulations.
    Proc Natl Acad Sci U S A. 2019;116:168-176.
    PubMed     Text format     Abstract available


    December 2018
  4. FURUSE Y
    Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers.
    Proc Natl Acad Sci U S A. 2018 Dec 31. pii: 1814484116.
    PubMed     Text format     Abstract available


    July 2018
  5. KINCAID RP, Lam VL, Chirayil RP, Randall G, et al
    RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus.
    Proc Natl Acad Sci U S A. 2018 Jul 23. pii: 1802326115.
    PubMed     Text format     Abstract available


  6. KE R, Li H, Wang S, Ding W, et al
    Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1805267115.
    PubMed     Text format     Abstract available


    June 2018
  7. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Text format     Abstract available


    December 2017
  8. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
    Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
    PubMed     Text format     Abstract available



  9. Correction for Giang et al., Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1720228115.
    PubMed     Text format    


    November 2017
  10. HIRANO J, Okamoto T, Sugiyama Y, Suzuki T, et al
    Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.
    Proc Natl Acad Sci U S A. 2017 Nov 29. pii: 1712484114.
    PubMed     Text format     Abstract available


    May 2017
  11. PADMANABHAN P, Dixit NM
    Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201704531.
    PubMed     Text format    


  12. OHASHI H, Koizumi Y, Fukano K, Wakita T, et al
    Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201705234.
    PubMed     Text format    


    April 2017
  13. HANSEN MD, Johnsen IB, Stiberg KA, Sherstova T, et al
    Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M.
    Proc Natl Acad Sci U S A. 2017 Apr 7. pii: 201616683.
    PubMed     Text format     Abstract available


    March 2017

  14. Correction for Koizumi et al., Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
    Proc Natl Acad Sci U S A. 2017 Mar 6. pii: 201702625.
    PubMed     Text format    


    February 2017
  15. KOIZUMI Y, Ohashi H, Nakajima S, Tanaka Y, et al
    Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 7. pii: 201610197.
    PubMed     Text format     Abstract available


  16. QI H, Chu V, Wu NC, Chen Z, et al
    Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
    Proc Natl Acad Sci U S A. 2017 Feb 3. pii: 201614623.
    PubMed     Text format     Abstract available


    December 2016
  17. LIU WL, Yang HC, Hsu CS, Wang CC, et al
    Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
    Proc Natl Acad Sci U S A. 2016 Dec 6. pii: 201618517.
    PubMed     Text format     Abstract available


    October 2016
  18. PIERCE BG, Keck ZY, Lau P, Fauvelle C, et al
    Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.
    Proc Natl Acad Sci U S A. 2016 Oct 26. pii: 201614942.
    PubMed     Text format     Abstract available


  19. KONG L, Lee DE, Kadam RU, Liu T, et al
    Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201609780.
    PubMed     Text format     Abstract available


  20. WOZNIAK AL, Long A, Jones-Jamtgaard KN, Weinman SA, et al
    Hepatitis C virus promotes virion secretion through cleavage of the Rab7 adaptor protein RILP.
    Proc Natl Acad Sci U S A. 2016 Oct 17. pii: 201607277.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: